Skip to main content
Start triage

Start triage first, then route to emergency care.

Need urgent help? Start triage first, then route to emergency care.

Roxee Meds Catalog

Frunevetmab

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Catalog complete FDA data linked Rx required Injection Zoetis Inc. Official label facts Owner quick guide first

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Storefront facts
Catalog refreshed
Apr 22, 2026, 10:09 a.m.

These are the storefront facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
May 5, 2026, 10:00 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
May 5, 2026, 10:01 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Storefront facts: Source Roxee | Refreshed Apr 22, 2026, 10:09 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: April 15, 2026

Updated: April 15, 2026, 10:04 AM UTC

Image coming soon
Frunevetmab

Frunevetmab

Drug type: Generic ingredient • Branded profile FDA branded products available

Both Injection Rx required 100% storefront ready

Species: Both

Manufacturer: Zoetis Inc.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Frunevetmab

Solensia (frunevetmab injection) is approved for cats for the control of pain associated with osteoarthritis. Species commonly shown: Cats.

Generic name
Frunevetmab
Brand names
Solensia
Medication class
branded
Manufacturer
Zoetis Inc.
Species
Cats
Dosage forms
Injection
Strengths
7 mg/mL
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
Solensia
Dosage forms
Injection
Strengths
7 mg/mL

Indications / Uses

Solensia (frunevetmab injection) is approved for cats for the control of pain associated with osteoarthritis.

Administration / How To Give

Administer by subcutaneous injection once a month, dosed by weight range, as directed and given by a veterinarian.

Warnings / Contraindications

Do not administer Solensia to cats with known hypersensitivity to frunevetmab.

  • Do not administer Solensia to cats with known hypersensitivity to frunevetmab; accidental self-injection can cause hypersensitivity reactions in people.

Side Effects

Top reported reactions (openFDA): General illness, Lethargy (see also Central nervous system depression in Neurological), Prescribing error, Anorexia, Behavioural disorder NOS, Confusion.

FAQ

Cats

Yes. Roxee shows this as prescription-only.

Injection

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Roxee still has limited plain-language guidance for this medication. Use the official documents and your veterinarian's instructions for product-specific details.

Used for:

Your vet decides this. Here's what owners typically ask/watch for.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • wobbly/unsteady walking (1 reports)
  • Loss of appetite (1 reports)
  • Hair loss (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Major cautions & emergency warning signs

Side effects to monitor:

  • wobbly/unsteady walking
  • Loss of appetite
  • Hair loss

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Loss of appetite (1 reports)
  • Hair loss (1 reports)

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Zoetis Inc.
Identifiers:
NDC Package: 54771-3520-1 NDC Package: 54771-3520-2 NDC Product: 54771

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
30
Species represented
1
Grouped by Body System
Digestive (2) · Loss of appetite, Bloody diarrhoea Skin & allergy (4) · Hair loss, Chewing - pruritus, Alopecia NOS Neurologic (1) · Unsteady walking (ataxia) Behavior (1) · Behavioral disorder (unspecified) Other (24) · Congestive heart failure, Confusion, Collapse NOS
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Cat 1
Digestive 1 Cat 1
Skin & allergy 1 Cat 1
Other 1 Cat 1
Other 1 Cat 1
Other 1 Cat 1
Other 1 Cat 1
Skin & allergy 1 Cat 1

Species coverage: Cat (32)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Cat Serious - 1
Digestive Cat Serious - 1
Skin & allergy Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Skin & allergy Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Digestive Cat Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Behavior Cat Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Skin & allergy Cat Serious - 1
Skin & allergy Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Source metadata:

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

2

SPL

1

FOI

0
No FOI links yet.

FDA Osteoarthritis in Cats

Official label / PI · Safety communication

This source does not expose a safe inline preview. Use the original source link for the full document.

FDA owner-facing context for osteoarthritis and Solensia in cats.

Solensia Official Label (DailyMed)

Official label / PI · Official label

This source does not expose a safe inline preview. Use the original source link for the full document.

Official Solensia label.

Solensia SPL

SPL · Structured Product Label

FDA Structured Product Label XML for Solensia. Use the source link for the full official labeling record.
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Storefront facts: Source Roxee | Refreshed Apr 22, 2026, 10:09 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Solensia
Manufacturer mapping: Zoetis Inc.
Case-reported brands (openFDA): MSK
Catalog species: Both
NDC: Packages 54771-3520-1 54771-3520-2 Products 54771
Safety (openFDA)
Top reactions: Dog 3 Cat 169 View
Case summaries: 37 (showing 8) View
openFDA reports are unverified and do not prove causation.

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Top reaction signals
Unsteady walking (ataxia) (1) Loss of appetite (1) Hair loss (1) Congestive heart failure (1) Confusion (1) Collapse NOS (1) Cold feeling to the touch (1) Chewing - pruritus (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NDC Package: 54771-3520-1 NDC Package: 54771-3520-2 NDC Product: 54771
Package NDC Product NDC Form / Route Status
54771-3520-1 54771 -
54771-3520-2 54771 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • FDA Osteoarthritis in Cats • Safety communication • Official
    FDA owner-facing context for osteoarthritis and Solensia in cats.
  • Solensia Official Label (DailyMed) • Official label • Official
    Official Solensia label.
  • Solensia SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 45 Clinical 8 Manufacturer 0 Marketing 0
Current Field Facts
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-21)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-20)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-19)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-17)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-15)
  • side_effects: Top reported reactions (openFDA): General illness, Lethargy (see also Central nervous system depression in Neurological), Prescribing error, Anorexia, Behaviou… (Clinical, 2026-04-11)
  • administration: Administer by subcutaneous injection once a month, dosed by weight range, as directed and given by a veterinarian. (Official, 2026-04-22)
  • approval_reference: NADA 141-546 (Official, 2026-04-22)
  • brand_names: Solensia (Official, 2026-04-22)
  • contraindications: Do not administer Solensia to cats with known hypersensitivity to frunevetmab. (Official, 2026-04-22)
  • dosage_forms: Injection (Official, 2026-04-22)
  • drug_profile_type: branded (Official, 2026-04-22)
  • manufacturer_name: Zoetis Inc. (Official, 2026-05-05)
  • manufacturer_name: Zoetis Inc. (Official, 2026-05-03)
  • manufacturer_name: Zoetis Inc. (Official, 2026-05-02)
  • manufacturer_name: Zoetis Inc. (Official, 2026-04-29)
  • manufacturer_name: Zoetis Inc. (Official, 2026-04-28)
  • manufacturer_name: Zoetis Inc. (Official, 2026-04-27)
Recent Revisions
  • monitoring updated 2026-05-05 10:07 by curated_loader • Monitoring summary based on official label adverse-reaction and administration sections.
  • contraindications updated 2026-05-05 10:07 by curated_loader • Official contraindication from the Solensia label.
  • prescription_required updated 2026-05-05 10:07 by curated_loader • Federal law restricts Solensia to use by or on the order of a licensed veterinarian.
  • administration updated 2026-05-05 10:07 by curated_loader • Official dosage and administration directions from the Solensia label.
  • strengths updated 2026-05-05 10:07 by curated_loader • Official label lists Solensia as 7 mg/mL frunevetmab injection.
  • dosage_forms updated 2026-05-05 10:07 by curated_loader • Official label describes Solensia as frunevetmab injection.
  • species updated 2026-05-05 10:07 by curated_loader • Official label states Solensia is for use in cats.
  • usage updated 2026-05-05 10:07 by curated_loader • Official indication from the Solensia label.
  • drug_profile_type updated 2026-05-05 10:07 by curated_loader • Solensia is the branded FDA-approved animal drug for frunevetmab injection.
  • manufacturer_name updated 2026-05-05 10:07 by curated_loader • Official Solensia label identifies Zoetis as the labeler/manufacturer.
  • brand_names updated 2026-05-05 10:07 by curated_loader • Official label identifies Solensia as the proprietary product name.
  • approval_reference updated 2026-05-05 10:07 by curated_loader • Official FDA application reference for Solensia.
  • monitoring updated 2026-05-03 10:07 by curated_loader • Monitoring summary based on official label adverse-reaction and administration sections.
  • contraindications updated 2026-05-03 10:07 by curated_loader • Official contraindication from the Solensia label.
  • prescription_required updated 2026-05-03 10:07 by curated_loader • Federal law restricts Solensia to use by or on the order of a licensed veterinarian.
  • administration updated 2026-05-03 10:07 by curated_loader • Official dosage and administration directions from the Solensia label.
  • strengths updated 2026-05-03 10:07 by curated_loader • Official label lists Solensia as 7 mg/mL frunevetmab injection.
  • dosage_forms updated 2026-05-03 10:07 by curated_loader • Official label describes Solensia as frunevetmab injection.
  • species updated 2026-05-03 10:07 by curated_loader • Official label states Solensia is for use in cats.
  • usage updated 2026-05-03 10:07 by curated_loader • Official indication from the Solensia label.

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published

Data source: FDA Animal Drugs @ FDA (public search export).

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Cat Bloody diarrhoea (1) • Cat

Showing top 5 for Digestive.

Skin & allergy
Hair loss (1) • Cat Chewing - pruritus (1) • Cat Alopecia NOS (1) • Cat Alopecia local (1) • Cat

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Cat

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Cat

Showing top 5 for Behavior.

Other
Congestive heart failure (1) • Cat Confusion (1) • Cat Collapse NOS (1) • Cat Cold feeling to the touch (1) • Cat Cardiac enlargement (1) • Cat
Show more (19)
Cardiac disorder NOS (1) • Cat Bruising (1) • Cat Bronchopulmonary inflammation (1) • Cat Breathing difficulty (1) • Cat Bone and joint disorder NOS (1) • Cat Blood in urine (1) • Cat Blood clot (1) • Cat Bladder distension (1) • Cat Barbering (1) • Cat Azotaemia (1) • Cat Arthritis (1) • Cat Arrhythmia (1) • Cat Anaemia NOS (1) • Cat Abrasion (1) • Cat Abnormal ultrasound finding (1) • Cat Abnormal radiograph finding (1) • Cat Abnormal movement NOS (1) • Cat Abnormal cytology (1) • Cat Abdominal pain (1) • Cat

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Cat (other), Male • Drug: MSK, Solution, Subcutaneous • Reactions: General illness, Unable to walk • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-075364
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
Reactions Reported:
General illness Unable to walk
Outcomes: Outcome Unknown

Cat, Domestic Longhair, Male, 8 year, 4.853 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 1 dose per animal • Reactions: Miliary dermatitis, Skin scab, Itching, Abnormal cytology, Pyoderma… • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-075203
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 8.00 Year
  • Weight: 4.853 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
  • Dose: 1 dose per animal
Reactions Reported:
Miliary dermatitis Skin scab Itching Abnormal cytology Pyoderma Partial lack of efficacy Skin lesion NOS Crust Skin sore
Outcomes: Outcome Unknown

Cat, Persian, Male, 12.5 year, 4.4 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 1 Vial per animal • Reactions: Intentional misuse, Lack of efficacy - NOS, Death by euthanasia, Gait abnormality, Lumbar pain • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-075165
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 12.50 Year
  • Weight: 4.400 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
  • Dose: 1 Vial per animal
Reactions Reported:
Intentional misuse Lack of efficacy - NOS Death by euthanasia Gait abnormality Lumbar pain
Outcomes: Euthanized

Cat, Cat (other), Female, 12 year • Drug: MSK, Solution, Subcutaneous • Reactions: Congestive heart failure, Death • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-075411
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Female
  • Age: 12.00 Year
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
Reactions Reported:
Congestive heart failure Death
Outcomes: Died

Cat, Domestic Shorthair, Male, 14 year, 9.072 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 14 Milligram per animal • Reactions: Vomiting, Hiding, Dazed, Heavy breathing, Death • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-075300
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 14.00 Year
  • Weight: 9.072 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
  • Dose: 14 Milligram per animal
Reactions Reported:
Vomiting Hiding Dazed Heavy breathing Death
Outcomes: Died

Cat, Domestic Mediumhair, Male, 15 year, 7.711 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 14 Milligram per animal • Reactions: Dermatitis, Hyperpigmentation • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075219
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 15.00 Year
  • Weight: 7.711 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
  • Dose: 14 Milligram per animal
Reactions Reported:
Dermatitis Hyperpigmentation
Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 11 year, 4.754 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 1 Vial per animal, Frequency: 1 per month • Reactions: Miliary dermatitis, Excoriation • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075455
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 11.00 Year
  • Weight: 4.754 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
  • Dose: 1 Vial per animal
  • Frequency: 1 per month
Reactions Reported:
Miliary dermatitis Excoriation
Outcomes: Ongoing

Cat, Domestic Shorthair, Male, 13 year, 6.876 kilogram • Drug: MSK, Injection, solution, Subcutaneous, Dose: 7 Milligram per animal • Reactions: Fever, Not eating, Neutrophilia, Monocytosis, Immune mediated haemolytic anaemia… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074332
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 13.00 Year
  • Weight: 6.876 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Injection, solution
  • Dose: 7 Milligram per animal
Reactions Reported:
Fever Not eating Neutrophilia Monocytosis Immune mediated haemolytic anaemia Behavioral disorder (unspecified) Decreased haematocrit
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.